Clinical outcomes
| Patient No. . | Age, y/sex, M/F . | Diagnosis/stage . | CD34 . | CD3 . | Day . | Survival, d . | Notes . | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| After A . | After G . | After A . | After G . | ANC more than 50 × 109/L . | Plt more than 20 × 109/L . | Plt more than 50 × 109/L . | |||||
| 1 | 51F | AML/CR2 | 2.6 | 2.9 | 4.9 | 1.3 | 11 | 14 | 21 | 964+ | |
| 2 | 54/M | ALL/Rel | 2.1 | 5.7 | 1.5 | 1.3 | NT | NT | NT | NT | |
| 3 | 50/M | AML/Rel | 1.2 | 2.5 | 2.7 | 6.8 | NT | NT | NT | NT | |
| 4 | 46/F | NHL/Rel | 2.5 | 2.8 | 6.8 | 1.2 | 11 | 20 | 25 | 774+ | |
| 5 | 31/M | AML/CR1 | 3.1 | 3.3 | 5.7 | 2.2 | 8 | 10 | 17 | 798+ | |
| 6 | 45/M | AML/Rel | 5.1 | NC | 1.9 | NC | 10 | 9 | 19 | 757+ | Alive in CR3 |
| 7 | 52/F | ALL/CR1 | 6.3 | 18.7 | 4.3 | 1.7 | 9 | 11 | 18 | 601+ | |
| 8 | 53/M | CML/AP | 2 | 5.0 | 3.8 | 1.2 | 13 | 32 | NR | 53 | Died; COD: GVHD |
| 9 | 37/F | NHL/Ref | 5.5 | 16.9 | 7.8 | 4.1 | 8 | 8 | 15 | 458 | Died; COD: pneumonia |
| 10 | 57/F | CLL/Rel | 1.5 | NC | 3 | NC | NT | NT | NT | NT | |
| 11 | 50/F | CLL/Ref | 1.9 | NC | 3.8 | NC | 10 | 15 | 18 | 196 | Died; COD: PD |
| 12 | 42/M | NHL/Ref | 2.9 | NC | 7.1 | NC | 11 | 13 | 17 | 365+ | |
| 13 | 59/F | AML/CR1 | 3.7 | NC | 3.7 | NC | 9 | 14 | 31 | 312+ | |
| 14 | 56/M | NHL/Rel | NC | NC | NC | NC | NT | NT | NT | NT | |
| 15 | 56/F | NHL/Ref | 4.1 | NC | 4.5 | NC | 8 | 12 | 12 | 83 | Died; COD: PD |
| 16 | 60/M | AML/Ref | 2.9 | NC | 6.2 | NC | 10 | 16 | 19 | 277+ | |
| 17 | 62/M | ALL/Rel | 2.3 | NC | 6.7 | NC | 10 | 11 | 21 | 270+ | |
| 18 | 55/F | ALL/CR1 | 2.1 | NC | 5.9 | NC | 9 | 10 | 17 | 265+ | |
| 19 | 34/M | AML/Rel | 3.7 | NC | 4.7 | NC | 5 | 22 | 25 | 255+ | |
| 20 | 53/F | NHL/Ref | 3.1 | NC | 6.7 | NC | 10 | 9 | 13 | 150 | Died; COD: PD |
| 21 | 62/F | MDS/RAEB | 3.2 | NC | 7.7 | NC | 9 | 11 | 15 | 153+ | |
| 22 | 40/F | AML/CR1 | 2.8 | NC | 2.6 | NC | 9 | 12 | 14 | 148+ | |
| 23 | 53/F | AML/Rel | 3.1 | NC | 5.8 | NC | NT | NT | NT | NT | |
| 24 | 51/F | CLL/Rel | 2.3 | NC | 2.8 | NC | 10 | 12 | 16 | 139+ | |
| 25 | 65/F | AML/Rel | 2.1 | NC | 4.5 | NC | 10 | 12 | 25 | 52 | Died; COD: PD |
| Patient No. . | Age, y/sex, M/F . | Diagnosis/stage . | CD34 . | CD3 . | Day . | Survival, d . | Notes . | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| After A . | After G . | After A . | After G . | ANC more than 50 × 109/L . | Plt more than 20 × 109/L . | Plt more than 50 × 109/L . | |||||
| 1 | 51F | AML/CR2 | 2.6 | 2.9 | 4.9 | 1.3 | 11 | 14 | 21 | 964+ | |
| 2 | 54/M | ALL/Rel | 2.1 | 5.7 | 1.5 | 1.3 | NT | NT | NT | NT | |
| 3 | 50/M | AML/Rel | 1.2 | 2.5 | 2.7 | 6.8 | NT | NT | NT | NT | |
| 4 | 46/F | NHL/Rel | 2.5 | 2.8 | 6.8 | 1.2 | 11 | 20 | 25 | 774+ | |
| 5 | 31/M | AML/CR1 | 3.1 | 3.3 | 5.7 | 2.2 | 8 | 10 | 17 | 798+ | |
| 6 | 45/M | AML/Rel | 5.1 | NC | 1.9 | NC | 10 | 9 | 19 | 757+ | Alive in CR3 |
| 7 | 52/F | ALL/CR1 | 6.3 | 18.7 | 4.3 | 1.7 | 9 | 11 | 18 | 601+ | |
| 8 | 53/M | CML/AP | 2 | 5.0 | 3.8 | 1.2 | 13 | 32 | NR | 53 | Died; COD: GVHD |
| 9 | 37/F | NHL/Ref | 5.5 | 16.9 | 7.8 | 4.1 | 8 | 8 | 15 | 458 | Died; COD: pneumonia |
| 10 | 57/F | CLL/Rel | 1.5 | NC | 3 | NC | NT | NT | NT | NT | |
| 11 | 50/F | CLL/Ref | 1.9 | NC | 3.8 | NC | 10 | 15 | 18 | 196 | Died; COD: PD |
| 12 | 42/M | NHL/Ref | 2.9 | NC | 7.1 | NC | 11 | 13 | 17 | 365+ | |
| 13 | 59/F | AML/CR1 | 3.7 | NC | 3.7 | NC | 9 | 14 | 31 | 312+ | |
| 14 | 56/M | NHL/Rel | NC | NC | NC | NC | NT | NT | NT | NT | |
| 15 | 56/F | NHL/Ref | 4.1 | NC | 4.5 | NC | 8 | 12 | 12 | 83 | Died; COD: PD |
| 16 | 60/M | AML/Ref | 2.9 | NC | 6.2 | NC | 10 | 16 | 19 | 277+ | |
| 17 | 62/M | ALL/Rel | 2.3 | NC | 6.7 | NC | 10 | 11 | 21 | 270+ | |
| 18 | 55/F | ALL/CR1 | 2.1 | NC | 5.9 | NC | 9 | 10 | 17 | 265+ | |
| 19 | 34/M | AML/Rel | 3.7 | NC | 4.7 | NC | 5 | 22 | 25 | 255+ | |
| 20 | 53/F | NHL/Ref | 3.1 | NC | 6.7 | NC | 10 | 9 | 13 | 150 | Died; COD: PD |
| 21 | 62/F | MDS/RAEB | 3.2 | NC | 7.7 | NC | 9 | 11 | 15 | 153+ | |
| 22 | 40/F | AML/CR1 | 2.8 | NC | 2.6 | NC | 9 | 12 | 14 | 148+ | |
| 23 | 53/F | AML/Rel | 3.1 | NC | 5.8 | NC | NT | NT | NT | NT | |
| 24 | 51/F | CLL/Rel | 2.3 | NC | 2.8 | NC | 10 | 12 | 16 | 139+ | |
| 25 | 65/F | AML/Rel | 2.1 | NC | 4.5 | NC | 10 | 12 | 25 | 52 | Died; COD: PD |
Plt indicates platelet count; CR, complete remission; Rel, relapsed; Ref, refractory; A, AMD3100; G, G-CSF; RAEB, refractory anemia with excess blasts; NT, never received transplant; NC, not collected; NR, not reached CR3, third complete remission; COD, cause of death; PD, progressive disease; and NE, not evaluable.